Vertex Pharma (VRTX) Granted European CHMP Positive Opinion for KALYDECO for Children/Adolescents with CF and R117H Mutation in CFTR Gene
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Vertex (VRTX) PT Raised to $305 at Citi
May 1, 2020 5:17 AM EDTCiti analyst Mohit Bansal raised the price target on Vertex (NASDAQ: VRTX) to $305.00 (from $265.00) while maintaining a Buy rating.... More
Vertex (VRTX) PT Raised to $305 at Citi
April 30, 2020 4:12 PM EDTCiti analyst Mohit Bansal raised the price target on Vertex (NASDAQ: VRTX) to $305.00 (from $265.00) while maintaining a Buy rating.
... MoreVertex (VRTX) PT Raised to $277 at Morgan Stanley
April 30, 2020 8:11 AM EDTMorgan Stanley raised its price target on Vertex (NASDAQ: VRTX) to $277.00 (from $258.00) while maintaining a Overweight rating.... More
Vertex (VRTX) PT Raised to $281 at Cantor Fitzgerald
April 30, 2020 6:34 AM EDTCantor Fitzgerald analyst Alethia Young raised the price target on Vertex (NASDAQ: VRTX) to $281.00 (from $275.00) while maintaining a Overweight rating.... More
Vertex (VRTX) PT Raised to $285 at Stifel
April 30, 2020 4:38 AM EDTStifel analyst Paul Matteis raised the price target on Vertex (NASDAQ: VRTX) to $285.00 (from $275.00) while maintaining a Buy rating.... More
Vertex (VRTX) PT Raised to $285 at JMP Securities
April 30, 2020 4:38 AM EDTJMP Securities analyst Joseph Osha raised the price target on Vertex (NASDAQ: VRTX) to $285.00 (from $255.00) while maintaining a Market Outperform rating.... More
Vertex Pharma (VRTX) Tops Q1 EPS by 72c, Revenues Beat; Raises FY20 Revenues Guidance
April 29, 2020 4:04 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $2.56, $0.72 better than the analyst estimate of $1.84. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.29 billion.
"The COVID-19 pandemic has presented unprecedented challenges to societies, communities and businesses around the world, and while these global challenges will... More
